194 related articles for article (PubMed ID: 29275295)
81. Immunohistochemical analysis of E-cadherin and zeste homolog 2 expression in endoscopic ultrasound-guided fine-needle aspiration of pancreatic adenocarcinoma.
Gao L; Antic T; Hyjek E; Gong C; Mueller J; Waxman I; DeMay RM; Reeves W
Cancer Cytopathol; 2013 Nov; 121(11):644-52. PubMed ID: 23674382
[TBL] [Abstract][Full Text] [Related]
82. Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study.
Moon J; Lee JH; Roh J; Lee DH; Ha EJ
Sci Rep; 2023 Mar; 13(1):4562. PubMed ID: 36941287
[TBL] [Abstract][Full Text] [Related]
83. The Long Non-Coding RNA
Pellecchia S; Sepe R; Decaussin-Petrucci M; Ivan C; Shimizu M; Coppola C; Testa D; Calin GA; Fusco A; Pallante P
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963578
[TBL] [Abstract][Full Text] [Related]
84. Immune Checkpoint Protein Expression Defines the Prognosis of Advanced Thyroid Carcinoma.
Luo Y; Yang YC; Shen CK; Ma B; Xu WB; Wang QF; Zhang Y; Liao T; Wei WJ; Wang Y
Front Endocrinol (Lausanne); 2022; 13():859013. PubMed ID: 35574031
[TBL] [Abstract][Full Text] [Related]
85. Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer.
Chen YH; Cabanillas M; Sperling J; Xu L; Goswami M; Maniakas A; Williams MD; Lai SY; Busaidy N; Dadu R; Zafereo ME; Wang JR
Thyroid; 2023 Mar; 33(3):321-329. PubMed ID: 36511380
[No Abstract] [Full Text] [Related]
86. Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.
Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
PLoS One; 2020; 15(2):e0229264. PubMed ID: 32092093
[TBL] [Abstract][Full Text] [Related]
87. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer.
Ryder M; Ghossein RA; Ricarte-Filho JC; Knauf JA; Fagin JA
Endocr Relat Cancer; 2008 Dec; 15(4):1069-74. PubMed ID: 18719091
[TBL] [Abstract][Full Text] [Related]
88. Mutations of genes including DNMT3A detected by next-generation sequencing in thyroid cancer.
Guo LC; Zhu WD; Ma XY; Ni H; Zhong EJ; Shao YW; Yu J; Gu DM; Ji SD; Xu HD; Ji C; Yang JM; Zhang Y
Cancer Biol Ther; 2019; 20(3):240-246. PubMed ID: 30252567
[TBL] [Abstract][Full Text] [Related]
89. Epidermal growth factor receptor 1 expression is upregulated in undifferentiated thyroid carcinomas in humans.
Landriscina M; Pannone G; Piscazzi A; Toti P; Fabiano A; Tortorella S; Occhini R; Ambrosi A; Bufo P; Cignarelli M
Thyroid; 2011 Nov; 21(11):1227-34. PubMed ID: 22007939
[TBL] [Abstract][Full Text] [Related]
90. Adding pieces to the puzzle of differentiated-to-anaplastic thyroid cancer evolution: the oncogene E2F7.
Gugnoni M; Lorenzini E; Faria do Valle I; Remondini D; Castellani G; Torricelli F; Sauta E; Donati B; Ragazzi M; Ghini F; Piana S; Ciarrocchi A; Manzotti G
Cell Death Dis; 2023 Feb; 14(2):99. PubMed ID: 36765037
[TBL] [Abstract][Full Text] [Related]
91. Small Cell Carcinoma: a Rare Subtype of Thyroid Cancer with Unanticipated Prognosis.
Shi W; Zhao QY; Liu ZM; Wang ST; Liu CP
Curr Med Sci; 2019 Apr; 39(2):265-269. PubMed ID: 31016520
[TBL] [Abstract][Full Text] [Related]
92. High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma.
Eichenauer T; Simmendinger L; Fraune C; Mandelkow T; Blessin NC; Kluth M; Hube-Magg C; Möller K; Clauditz T; Weidemann S; Dahlem R; Fisch M; Riechardt S; Simon R; Sauter G; Büscheck F; Rink M
World J Urol; 2021 Feb; 39(2):481-490. PubMed ID: 32303902
[TBL] [Abstract][Full Text] [Related]
93. Prognostic role of EZH2 in gliomas: a meta-analysis.
Pyo JS; Kang DW
Int J Biol Markers; 2018 Jan; 33(1):62-67. PubMed ID: 28862715
[TBL] [Abstract][Full Text] [Related]
94. The function and molecular mechanism of CEP55 in anaplastic thyroid cancer.
Li YH; Xu KC; Huang GM; Zang HL
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9549-9555. PubMed ID: 33015797
[TBL] [Abstract][Full Text] [Related]
95. Dedifferentiation patterns in DTC: is PDTC an intermediate state between DTC and ATC?
Wen D; Hu JQ; Wei WJ; Ma B; Lu ZW; Wang YL; Wang Y; Ji QH
Int J Clin Exp Pathol; 2019; 12(1):267-274. PubMed ID: 31933742
[TBL] [Abstract][Full Text] [Related]
96. New Insights into Immune Cells and Immunotherapy for Thyroid Cancer.
Tao Y; Li P; Feng C; Cao Y
Immunol Invest; 2023 Nov; 52(8):1039-1064. PubMed ID: 37846977
[TBL] [Abstract][Full Text] [Related]
97. Prognostic Factors and Survival Score for Patients With Anaplastic Thyroid Carcinoma: A Retrospective Study from a Regional Registry.
Marchand-Crety C; Pascard M; Debreuve-Theresette A; Ettalhaoui L; Schvartz C; Zalzali M; Brugel M; Bellefqih S; Servagi-Vernat S
Anticancer Res; 2021 Mar; 41(3):1555-1561. PubMed ID: 33788749
[TBL] [Abstract][Full Text] [Related]
98. Age Influences the Prognosis of Anaplastic Thyroid Cancer Patients.
Kong N; Xu Q; Zhang Z; Cui A; Tan S; Bai N
Front Endocrinol (Lausanne); 2021; 12():704596. PubMed ID: 34385977
[TBL] [Abstract][Full Text] [Related]
99. Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience.
Romei C; Tacito A; Molinaro E; Piaggi P; Cappagli V; Pieruzzi L; Matrone A; Viola D; Agate L; Torregrossa L; Ugolini C; Basolo F; De Napoli L; Curcio M; Ciampi R; Materazzi G; Vitti P; Elisei R
Oncol Lett; 2018 Jun; 15(6):9174-9182. PubMed ID: 29805648
[TBL] [Abstract][Full Text] [Related]
100. Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignancies.
Woelfl S; Bogner S; Huber H; Salaheddin-Nassr S; Hatzl M; Decristoforo C; Virgolini I; Gabriel M
Nuklearmedizin; 2014; 53(5):179-85. PubMed ID: 24967740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
